Karl-Gösta Ljungström. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Anaphylaxis/chemically inducedAnaphylaxis/immunologyAnaphylaxis/prevention & controlAntibody Formation/drug effectsAntibody Formation/immunologyDextrans/administration & dosageDextrans/adverse effectsDextrans/immunologyHumansPremedicationProduct Surveillance, PostmarketingRisk Factors
Substances: See more » Dextrans
Year: 2006 PMID: 16678710 DOI: 10.1016/j.jvs.2005.11.056
Source DB: PubMed Journal: J Vasc Surg ISSN: 0741-5214 Impact factor: 4.268